Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 94
- Uncategorized
Missouri Court Officials Request $3.7m to Continue Cannabis Expungements
Missouri Court officials have requested a further $3.7m to fund its ongoing commitment to cannabis expungements over the coming year.
- Markets & Stocks
Akanda Avoids NASDAQ Delisting, Kanabo to Open Walk-in Clinic, & Hellenic Makes Funding Progress
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its stock rise by around 7% this week as it rode the wave of positive sentiment sending US-listed cannabis stocks skyrocketing.
- Uncategorized
US Cannabis Stock Prices up 25% Since Publication of Rescheduling Recommendation
US cannabis stock prices have rallied once again this week following the publication of the fully unredacted 252-page cannabis rescheduling recommendation.
- Press releases
Medical Cannabis Significantly Improves Symptoms of Chronic Depression, New Study Suggests
LVR University Hospital Essen, in collaboration with Algea Care, Europe’s leading telehealth platform for cannabis, has announced the results of a groundbreaking study on the efficacy of medical cannabis in treating chronic depression: patients showed significant improvement, with the reported severity rate of their depression reduced significantly, with no severe side effects and a low…
- Uncategorized
Teva Pharmaceuticals Fails to Disqualify Jazz Pharmaceuticals’ Epidyolex Patent In Court
Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent for Epidyolex, a cannabis-based drug worth hundreds of millions of dollars a year.
- Uncategorized
Colorado’s Cannabis Market Hit Lowest Sales Since 2015 in November 2023
Colorado’s cannabis market continued its substantial decline in the closing months of 2023, seeing cannabis sales fall to their lowest level since February 2015 in November.
- Press releases
Kanabo Announces Partnership With City Dock Pharmacy to Launch a Walk-in Pain Clinic
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce it has signed a partnership with City Dock Pharmacy in London, to launch a walk-in pain clinic offering specialised medicines, including medicinal cannabis, which is the first of its kind.
- Uncategorized
US Government Releases Full Unredacted Cannabis Rescheduling Recommendation, Confirming Medical Uses
The fully unredacted 252-page cannabis rescheduling recommendation has finally been made public, confirming for the first time that cannabis has medical uses.
- Press releases
GrowerIQ Completes Acquisition of Ample Organics, Establishing Market Leadership in Cannabis Technology
GrowerIQ, a prominent cannabis technology company, is thrilled to announce its successful acquisition of Ample Organics, a pioneering force in Canadian cannabis technology.
- Adult-Use
Czech Republic’s Plans to Roll Back Adult-Use Actually Political Ploy to Pressure Bill’s Opponents, Say Insiders
Last week the Czech government published a draft version of its highly anticipated cannabis regulation bill, sparking outrage due to the apparent omission of plans for a full commercial market.
- Medical
German Medical Cannabis Associations Call For Wider Regulatory Reform
As reported by Cannabis Health German associations have called for wider reforms to medical cannabis regulations to ‘reduce bureaucracy’ and open up access for patients.
- Uncategorized
Deutsche Verbände für medizinisches Cannabis fordern eine umfassendere Regulierungsreform
Wie berichtet von Cannabis Gesundheit Deutsche Verbände haben eine umfassende Reform der Vorschriften für medizinisches Cannabis gefordert, um “Bürokratie abzubauen” und den Zugang für Patienten zu erleichtern.










